Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.3 USD | -2.99% |
|
-4.41% | -50.38% |
05-09 | Transcript : Apyx Medical Corporation, Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Stavros Vizirgianakis Enters into Letter Agreement with Apyx Medical | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.38% | 46.42M | |
-6.24% | 181B | |
-6.39% | 101B | |
-5.97% | 67.54B | |
-9.61% | 45.09B | |
+8.84% | 44.37B | |
+5.36% | 40.7B | |
+12.69% | 29.85B | |
+10.26% | 24.49B | |
-7.83% | 23.99B |
- Stock Market
- Equities
- APYX Stock
- News Apyx Medical Corporation
- Apyx Medical Receives FDA 510(k) Clearance for the Renuvion Micro Handpiece; Shares Rise Pre-Bell